Mark Coles is a senior lecturer in the Centre for Immunology and Infection and Hull York Medical School since 2006 and is Chief Scientific Officer of SimOmics a start-up company using computer modelling to replace mice in the drug discovery process. His laboratory uses a combination of tissue engineering, imaging and computer modelling to understand how the immune system works.
“I’m interested in infectious disease, autoimmune response and tumour metastasis and how the immune system can be manipulated to treat human disease. Through funding from NC3Rs the laboratory has been building an artificial human lymph node which will be a unique tool to understand how the human immune system functions. This work will be presented at the NC3Rs stand.”